Litcius/Paper detail

Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia

Isabel Guthridge, Simon Smith, Matthew Law, Enzo Binotto, Josh Hanson

2021Antimicrobial Agents and Chemotherapy14 citationsDOIOpen Access PDF

Abstract

= 0.02). Lincosamides appear to have utility, at least as stepdown therapy, in the treatment of MRSA bacteremia, particularly in young, clinically stable patients with few comorbidities in whom endocarditis has been excluded. Prospective studies will help define their optimal role.

Topics & Concepts

MedicineBacteremiaInternal medicineRegimenOdds ratioCase fatality rateMethicillin-resistant Staphylococcus aureusSurgeryAntibioticsStaphylococcus aureusEpidemiologyMicrobiologyBacteriaGeneticsBiologyAntimicrobial Resistance in StaphylococcusBacterial Identification and Susceptibility TestingAntibiotics Pharmacokinetics and Efficacy
Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia | Litcius